Andreas Halvorsen - Viking Global Investors
Holding/activity history for Gw Pharmaceuticals Plc (GWPH)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2018 Q1 | 0 | 0.00 | Sell 100.00% | 0.18 | SEC | ||
| 2017 Q4 | 211,869 | 0.18 | Reduce 69.90% | 0.34 | $132.01 | $27,969,000 | SEC |
| 2017 Q3 | 703,856 | 0.48 | Reduce 19.40% | 0.12 | $101.49 | $71,434,000 | SEC |
| 2017 Q2 | 873,308 | 0.60 | Add 4.64% | 0.03 | $100.25 | $87,549,000 | SEC |
| 2017 Q1 | 834,605 | 0.46 | Reduce 8.37% | 0.04 | $120.94 | $100,937,000 | SEC |
| 2016 Q4 | 910,831 | 0.47 | Reduce 7.31% | 0.04 | $111.75 | $101,785,000 | SEC |
| 2016 Q3 | 982,655 | 0.58 | Add 18.17% | 0.09 | $132.73 | $130,428,000 | SEC |
| 2016 Q2 | 831,547 | 0.33 | Buy | 0.33 | $91.57 | $76,145,000 | SEC |